4Bateman E D, Boushey H A, Bousquet J, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study [J]. Am J Respir Crit Care Med , 2004, 170(8) : 836 -844.
5American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions [J]. Am J Respir Crit Care Med, 2000, 162(6) : 2341 -2351.
6Wenzel S E, Schwartz L B, Langmack E L, et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics [J ]. Am J Respir Crit Care Med, 1999 , 160(3) : 1001 -1008.
7Matsuoka H, Niimi A, Matsumoto H, et al. Inflammatory subtypes in cough-variant asthma: association with maintenance doses of inhaled corticosteroids [J]. Chest, 2010, 138(6): 1418-1425.
8Cowan D C, Cowan J O, Palmay R, et al. Effects of steroid therapy on inflammatory cell subtypes in asthma [J]. Thorax, 2010, 65(5) : 384 -390.
9Moore W C, Meyers D A, Wenzel S E, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program [J]. Am J Respir Crit Care Med, 2010, 181(4) : 315 -323.
10Green R H, Brightling C E, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial [J]. Lancet, 2002, 360(9347) : 1715 - 1721.
